Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00681369
First received: May 20, 2008
Last updated: January 21, 2011
Last verified: January 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2007 |
| Estimated Primary Completion Date: | No date given |